StockData
Vericel Corp logo

Vericel Corp (VCEL) stock

VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/30325% above fair value
$57.48+0.52 (+0.91%)

Close on Nov 16, 2026Market cap $2.94BP/E 136.9Yield –

Vericel market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Vericel's market cap was $3.04B on Nov 11, 2026, against $2.03B a year earlier. Over the last 5 years it ranged from $1.08B to $3.04B, with a median of $1.82B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.04B+67.1%
2025Dec 31, 2025$1.82B-32.7%
2024Dec 31, 2024$2.71B+59.3%
2023Dec 29, 2023$1.70B+36.6%
2022Dec 30, 2022$1.24B-32.4%
2021Dec 31, 2021$1.84B+31.3%
2020Dec 31, 2020$1.40B+80.6%
2019Dec 31, 2019$774.65M+3.1%
2018Dec 31, 2018$751.16M+295.5%
2017Dec 29, 2017$189.94M+166.2%
2016Dec 30, 2016$71.36M+16.3%
2015Dec 31, 2015$61.37M-15.1%
2014Dec 31, 2014$72.31M+418.0%
2013Dec 31, 2013$13.96M-74.7%
2012Dec 31, 2012$55.17M+22.6%
2011Dec 30, 2011$45.01M-28.9%
2010Dec 31, 2010$63.31M+42.8%
2009Dec 31, 2009$44.33M–

More Vericel figures

See a number that looks wrong?